Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer

Published:2018-12-20 Issue:4 Volume:111 Page:431-434
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Kehl Kenneth L¹²,Lathan Christopher S¹²,Johnson Bruce E²,Schrag Deborah¹

Affiliation:

1. Division of Population Sciences

2. Thoracic Oncology Program, Dana-Farber Cancer Institute, Boston, MA

Funder

California Department of Public Health

California Health and Safety

National Cancer Institute

Cancer Prevention Institute of California

University of Southern California

Public Health Institute

Centers for Disease Control and Prevention

National Program of Cancer Registries

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/111/4/431/28279491/djy202.pdf

Reference15 articles.

1. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy;Keedy;J Clin Oncol.,2011

2. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

3. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden;Hellmann;N Engl J Med.,2018

4. Racial differences in the treatment of early-stage lung cancer;Bach;N Engl J Med.,1999

5. Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010–2013;Lynch;BMC Cancer.,2018

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seeking Precision Healthcare in Rural Patients With Cancer: Learning Self-advocacy;Cancer Nursing;2024-08-26

2. Biomarker Testing for Guiding Precision Medicine for Patients with Non-Small Cell Lung Cancer;CHEST;2024-08

3. Health Care Provider Practices and Perceptions of Biomarker Testing in US Veterans With Non-Small Cell Lung Cancer;CHEST;2024-08

4. Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022;Cancer Epidemiology, Biomarkers & Prevention;2024-06-17

5. Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review;JNCI: Journal of the National Cancer Institute;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3